Skip to main content

Closed

IOVA: Iovance Biotherapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-127.2%

ROIC-45.3%

Financially safe

Stretched

Debt / equity0.07×

Interest coverage0.0×

Current ratio3.60×

Iovance Biotherapeutics, Inc.

IOVANASDAQ Global Market·USD·Closed

Iovance Biotherapeutics, Inc.

IOVANASDAQ·USD·Closed

$4.07

−13.22%

$4.07

−$0.62 (13.22%)

52W Range

60thpctl

Volume

1.29×avg

Mkt Cap

1.82BUSD

P/E

-4.4TTM

Div Yield

–ann

52W Range

60thpctl

Volume

1.29×avg

Market Cap

1.82BUSD

P/E Ratio

-4.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings